ImageneBio, Inc.

IMA
$5.63 (- $0.02 - 0.35%)
Last updated: 2026-06-09 04:23 UTC
IMA Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS45175G2075
CUSIP45175G207
Market Price5.63
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-4.77
Market Cap$65.4M
Book Value13.13
Price to Book0.446
BetaN/A
52w High20.4
52w Low5.76
Next Earnings DateN/A

ImageneBio, Inc. trades under ticker IMA on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US45175G2075, CUSIP 45175G207.

About the Company
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
Price History